BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15012010)

  • 1. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols.
    Levin-Plotnik D; Hamilton RJ
    Phys Med Biol; 2004 Feb; 49(3):407-24. PubMed ID: 15012010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the effect of clonogen resensitization on the tumor response to fractionated external radiotherapy.
    Stavreva NA; Warkentin B; Stavrev PV; Fallone BG
    Med Phys; 2005 Mar; 32(3):720-5. PubMed ID: 15839343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should single or distributed parameters be used to explain the steepness of tumour control probability curves?
    Daşu A; Toma-Daşu I; Fowler JF
    Phys Med Biol; 2003 Feb; 48(3):387-97. PubMed ID: 12608614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the inclusion of proliferation in tumour control probability calculations for inhomogeneously irradiated tumours.
    Tomé WA; Fowler JF
    Phys Med Biol; 2003 Sep; 48(18):N261-8. PubMed ID: 14529214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of local control due to tumor displacement as a function of margin size, dose-response slope, and number of fractions.
    Selvaraj J; Uzan J; Baker C; Nahum A
    Med Phys; 2013 Apr; 40(4):041715. PubMed ID: 23556885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards biologically conformal radiation therapy (BCRT): selective IMRT dose escalation under the guidance of spatial biology distribution.
    Yang Y; Xing L
    Med Phys; 2005 Jun; 32(6):1473-84. PubMed ID: 16013703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some characteristics of tumour control probability for heterogeneous tumours.
    Ebert MA; Hoban PW
    Phys Med Biol; 1996 Oct; 41(10):2125-33. PubMed ID: 8912385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose prescription complexity versus tumor control probability in biologically conformal radiotherapy.
    South CP; Evans PM; Partridge M
    Med Phys; 2009 Oct; 36(10):4379-88. PubMed ID: 19928068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viability of the EUD and TCP concepts as reliable dose indicators.
    Ebert MA
    Phys Med Biol; 2000 Feb; 45(2):441-57. PubMed ID: 10701514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the equivalent uniform stochastic dose (EUSD) to TCP calculations incorporating dose uncertainty and fractionation effects.
    Zavgorodni S
    Australas Phys Eng Sci Med; 2008 Mar; 31(1):1-9. PubMed ID: 18488958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.
    Fenwick JD
    Phys Med Biol; 1998 Aug; 43(8):2159-78. PubMed ID: 9725596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
    Keall PJ; Webb S
    Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On differences in radiosensitivity estimation: TCP experiments versus survival curves. A theoretical study.
    Stavrev P; Stavreva N; Ruggieri R; Nahum A
    Phys Med Biol; 2015 Aug; 60(15):N293-9. PubMed ID: 26215150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal number and sizes of the doses in fractionated radiotherapy according to the LQ model.
    Bruni C; Conte F; Papa F; Sinisgalli C
    Math Med Biol; 2019 Mar; 36(1):1-53. PubMed ID: 29346681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study.
    Duan J; Shen S; Fiveash JB; Popple RA; Brezovich IA
    Med Phys; 2006 May; 33(5):1380-7. PubMed ID: 16752574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
    Mackay RI; Hendry JH
    Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUD-based radiotherapy treatment plan evaluation: incorporating physical and Monte Carlo statistical dose uncertainties.
    Cranmer-Sargison G; Zavgorodni S
    Phys Med Biol; 2005 Sep; 50(17):4097-109. PubMed ID: 16177533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of normal tissue response and individualization of doses in radiotherapy.
    Guirado D; Ruiz de Almodóvar JM
    Phys Med Biol; 2003 Oct; 48(19):3213-23. PubMed ID: 14579861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Xiong W; Li J; Ma CM
    Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.